We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current KALA market cap is 32.67M. The company's latest EPS is USD -9.1586 and P/E is -0.78.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 230k | 0 | 0 | 0 | 0 |
| Operating Income | -11.68M | -9.6M | -8.76M | -9.62M | -11.93M |
| Net Income | -14.46M | -10.41M | -8.7M | -8.63M | -11.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.07M | 6.36M | 17.05M | 4.18M | 230k |
| Operating Income | -88.22M | -96.23M | -130.25M | -81.71M | -39.66M |
| Net Income | -94.35M | -104.33M | -142.61M | -44.82M | -42.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 72.23M | 66.5M | 61.12M | 55.95M | 53.03M |
| Total Liabilities | 48.77M | 49.01M | 49.9M | 48.45M | 46.37M |
| Total Equity | 23.46M | 17.49M | 11.22M | 7.5M | 6.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.32M | 221.61M | 139.43M | 86.82M | 55.95M |
| Total Liabilities | 124.63M | 121.61M | 122.62M | 67.85M | 48.45M |
| Total Equity | 29.69M | 100M | 16.8M | 18.97M | 7.5M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.68M | -17.28M | -20.23M | -27.93M | -10.84M |
| Investing | -108k | -10.14M | -422k | -429k | -13k |
| Financing | 2.86M | 5.93M | 5.97M | 8.51M | 8.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.72M | -90.69M | -108.24M | -78.91M | -27.93M |
| Investing | -1.34M | -78.21M | 70.8M | 62.72M | -429k |
| Financing | 8.98M | 160.63M | 42.55M | -7.94M | 8.51M |
| Market Cap | 32.67M |
| Price to Earnings Ratio | -0.78 |
| Price to Sales Ratio | 142.89 |
| Price to Cash Ratio | 0.65 |
| Price to Book Ratio | 4.38 |
| Dividend Yield | - |
| Shares Outstanding | 4.61M |
| Average Volume (1 week) | 54.09k |
| Average Volume (1 Month) | 33.47k |
| 52 Week Change | 28.91% |
| 52 Week High | 10.97 |
| 52 Week Low | 4.21 |
| Spread (Intraday) | 0.74 (9.52%) |
| Company Name | KALA BIO Inc |
| Address |
corporation trust center watertown, massachusetts 19801 |
| Website | https://www.kalarx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
